TeamViewer (TMV) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Revenue grew 8% year-over-year in constant currency for Q3, reaching €169 million, with all regions and customer categories contributing positively despite challenging macroeconomic conditions.
Enterprise segment delivered 23% revenue growth and 20% ARR growth year-over-year, now comprising 22% of total revenue, reflecting a strategic shift toward enterprise customers.
Adjusted EBITDA margin reached a record 48% in Q3, up 4 percentage points year-over-year, supported by cost discipline and reduced marketing spend.
Net income increased 49% year-over-year to €39.5 million, and adjusted EPS rose 30% to €0.29.
FY 2024 revenue guidance narrowed to €662m–€668m, and adjusted EBITDA margin guidance raised to at least 44%.
Financial highlights
Q3 2024 revenue: €168.7m (+7% reported, +8% cc); ARR: €669.3m (+7% cc); billings: €154.1m (+4% cc).
Adjusted EBITDA: €81.0m (+15% yoy); margin: 48% (+4pp yoy).
Net income: €39.5m (+49% yoy); adjusted EPS: €0.29 (+30% yoy).
Levered free cash flow: €41.3m in Q3; €143m year-to-date, flat yoy.
Billings grew 4% yoy in constant currency; multi-year deals with upfront payment reached €70m (+10% yoy).
Outlook and guidance
FY 2024 revenue expected between €662m–€668m, reflecting 7–8% growth in constant currency.
Adjusted EBITDA margin guidance raised to at least 44%, up from previous guidance of at least 43%.
Guidance incorporates FX headwinds of €10–11m for the full year.
Expect low single-digit billings growth in Q4 due to tough comps and ongoing macro headwinds.
Pipeline for Q4 and 2025 remains solid, but management remains cautious due to market uncertainty.
Latest events from TeamViewer
- 5% revenue and 8% EBITDA growth in 2025; 2026 outlook cautious with 0–3% growth target.TMV
Q4 202510 Feb 2026 - Q2 2024 delivered strong growth, high margins, and reaffirmed full-year guidance.TMV
Q2 20242 Feb 2026 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement11 Jan 2026 - FY 2024 exceeded guidance with strong Enterprise growth, 1E integration, and margin expansion.TMV
Q4 202416 Dec 2025 - Enterprise ARR up 21%, revenue and EBITDA both rise 7% and 20% year-over-year, outlook confirmed.TMV
Q1 202519 Nov 2025 - Q2 revenue up 6% and adjusted EBITDA up 17%, driven by enterprise gains and new product launches.TMV
Q2 202516 Nov 2025 - Q3 delivered 4% growth and 46% margin, but 1E weakness led to lower ARR guidance for 2025.TMV
Q3 202522 Oct 2025